Viking Stock Analysis

VKTX -  USA Stock  

USD 6.30  0.22  3.62%

The small slide in market price for the last few months may raise some interest from investors as it is trading at a share price of 6.30 on 1,011,172 in trading volume. The company executives did not add much value to Viking Thera investors in May. However, diversifying your holdings with Viking Thera or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.13. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Viking Thera partners.
Also, please take a look at World Market Map.

Search Stock Analysis 

 
Refresh
The Viking Thera stock analysis report makes it easy to digest most publicly released information about Viking Thera and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Viking stock analysis module also helps to analyze the Viking Thera price relationship with some important fundamental indicators such as market cap and management efficiency.

Viking Stock Analysis Notes

About 50.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.98. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viking Thera recorded a loss per share of 0.6. The entity had not issued any dividends in recent years. Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Viking Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 18 people. For more information please call Brian Lian at 858 704 4660 or visit http://www.vikingtherapeutics.com.

Viking Thera Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Viking Thera's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Viking Thera or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Viking Thera generates negative expected return over the last 90 days
Viking Thera has high historical volatility and very poor performance
Net Loss for the year was (43.82 M) with profit before overhead, payroll, taxes, and interest of 0.
Viking Thera currently holds about 241.68 M in cash with (28.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09.
Latest headline from MacroaxisInsider: Purchase by Matthew Foehr of 20000 shares of Viking Thera

Viking Thera Upcoming and Recent Events

Earnings reports are used by Viking Thera to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Viking Thera previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report14th of March 2017
Next Earnings Report9th of May 2017
Next Fiscal Quarter End31st of December 2016
Next Fiscal Year End14th of March 2017
Last Quarter Report30th of September 2016
Last Earning Announcement31st of December 2015

Viking Largest EPS Surprises

Earnings surprises can significantly impact Viking Thera's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-05-02
2019-03-31-0.0856-0.070.015618 
2018-08-09
2018-06-30-0.1113-0.13-0.018716 
2020-10-28
2020-09-30-0.15-0.130.0213 
View All Earnings Estimates

Viking Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 474.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viking Thera's market, we take the total number of its shares issued and multiply it by Viking Thera's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (10.89) % which means that it has lost $10.89 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (17.34) %, meaning that it created substantial loss on money invested by shareholders. Viking Thera management efficiency ratios could be used to measure how well viking thera manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Viking Thera has the risk adjusted performance of (0.016622), and Coefficient Of Variation of (2,540). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viking Thera, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Viking Thera, which can be compared to its competition. Please validate Viking Thera value at risk, and the relationship between the jensen alpha and semi variance to decide if Viking Thera is priced more or less accurately, providing market reflects its prevalent price of 6.3 per share. Given that Viking Thera has jensen alpha of (0.16), we advise you to double-check Viking Thera's current market performance to make sure the company can sustain itself at a future point.

Viking Thera Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Viking Thera more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Viking Thera Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Viking Thera insiders, such as employees or executives, is commonly permitted as long as it does not rely on Viking Thera's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Viking Thera insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Matthew Foehr six days ago via Macroaxis 
Purchase by Matthew Foehr of 20000 shares of Viking Thera
Matthew Foehr over two months ago via Macroaxis 
Exercise of in-the-money or at-the-money derivative position by Matthew Foehr of 20000 shares of Viking Thera
Mancini Marianna over three months ago via Macroaxis 
Payment of 994 shares by Mancini Marianna of Viking Therapeutics subject to Rule 16b-3
Mancini Marianna over three months ago via Macroaxis 
Acquisition by Mancini Marianna of 90000 shares of Viking Therapeutics subject to Rule 16b-3
Charles Rowland over three months ago via Macroaxis 
Acquisition by Charles Rowland of 22000 shares of Viking Therapeutics subject to Rule 16b-3
Brian Lian over six months ago via Macroaxis 
Payment of 19192 shares by Brian Lian of Viking Therapeutics subject to Rule 16b-3
Ligand Pharmaceuticals Inc over six months ago via Macroaxis 
Sale by Ligand Pharmaceuticals Inc of 148700 shares of Viking Therapeutics
Ligand Pharmaceuticals Inc over six months ago via Macroaxis 
Sale by Ligand Pharmaceuticals Inc of 94488 shares of Viking Therapeutics
Matthew Foehr over six months ago via Macroaxis 
Sale by Matthew Foehr of 13000 shares of Viking Therapeutics
Singleton J Matthew over a year ago via Macroaxis 
Acquisition by Singleton J Matthew of 22000 shares of Viking Therapeutics subject to Rule 16b-3
Michael Morneau over a year ago via Macroaxis 
Acquisition by Michael Morneau of 15000 shares of Viking Therapeutics subject to Rule 16b-3
Rouan Sarah Kathryn over a year ago via Macroaxis 
Acquisition by Rouan Sarah Kathryn of 22000 shares of Viking Therapeutics subject to Rule 16b-3

Viking Thera Predictive Daily Indicators

Viking Thera intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Viking Thera stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Viking Thera Forecast Models

Viking Thera time-series forecasting models is one of many Viking Thera's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viking Thera's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Viking Thera Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Viking Thera stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viking shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Viking Thera. By using and applying Viking Stock analysis, traders can create a robust methodology for identifying Viking entry and exit points for their positions.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Viking Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 18 people.

Current Viking Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Viking analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Viking analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
7.06Strong Buy4Odds
Viking Thera current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Viking analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Viking stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Viking Thera, talking to its executives and customers, or listening to Viking conference calls.
Viking Analyst Advice Details

Viking Stock Analysis Indicators

Viking Thera stock analysis indicators help investors evaluate how Viking Thera stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Viking Thera shares will generate the highest return on investment. By understating and applying Viking Thera stock analysis, traders can identify Viking Thera position entry and exit signals to maximize returns.
Shares Percent Shares Out14.21%
Quick Ratio18.71
Fifty Two Week Low4.95
Short Percent Of Float16.72%
Forward Price Earnings-5.63
Float Shares60.54M
Fifty Two Week High10.09
Shares Short Prior Month8.52M
Average Daily Volume Last 10 Day956.11k
Average Daily Volume In Three Month959.2k
Fifty Day Average5.80
Two Hundred Day Average6.46
Also, please take a look at World Market Map. Note that the Viking Thera information on this page should be used as a complementary analysis to other Viking Thera's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Viking Thera Stock analysis

When running Viking Thera stock analysis, check to measure Viking Thera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Thera is operating at the current time. Most of Viking Thera's stock examination focuses on studying past and present price action to predict the probability of Viking Thera's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Viking Thera's price. Additionally, you may evaluate how the addition of Viking Thera to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Viking Thera is measured differently than its book value, which is the value of Viking that is recorded on the company's balance sheet. Investors also form their own opinion of Viking Thera stock's value that differs from its market value or its book value, called intrinsic value, which is Viking Thera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viking Thera's market value can be influenced by many factors that don't directly affect Viking Thera underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Viking Thera's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Viking Thera value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viking Thera's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.